posted stronger-than-expected third quarter earnings Wednesday, powered by gains in its pharmacy and health care benefits division, but stuck to its full-year profit forecasts.
Pharmacy & Consumer sales, which were formerly reported in the Retail segment, were up 6% to $28.87 billion,"driven increased prescription volume and brand inflation,' CVS said. Health Care Benefits revenues were up 16.9% to $26.3 billion.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
CVS Health’s stock up after earnings beat, but company lowers full-year EPS guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leggi di più »